Showing results (261-270 of 394) with videos related to
Sort By:
Pageof 40
Arteriosclerosis, Thrombosis, and Vascular Biology|January 31, 2009
Dominant-negative loss of PPARgamma function enhances smooth muscle cell proliferation, migration, and vascular remodelingDane Meredith, Manikandan Panchatcharam, Sumitra Miriyala, et al.The Biochemical Journal|June 24, 2011
Autotaxin induces lung epithelial cell migration through lysoPLD activity-dependent and -independent pathwaysJing Zhao, Donghong He, Evgeny Berdyshev, et al.Plos Genetics|April 4, 2015
Lipid-induced epigenomic changes in human macrophages identify a coronary artery disease-associated variant that regulates PPAP2B Expression through Altered C/EBP-beta bindingMichael E Reschen, Kyle J Gaulton, Da Lin, et al.The Journal of Clinical Endocrinology and Metabolism|June 1, 1988
A novel type of pituitary adenoma: morphological features and clinical correlationsE Horvath, K Kovacs, H S Smyth, et al.Acta Neurochirurgica|January 1, 1980
Correlative ultrastructural morphometry of human prolactin-producing adenomasD J McComb, K Kovacs, E Horvath, et al.Biochemistry|May 31, 1994
Nonhydrolyzable phosphotyrosyl mimetics for the preparation of phosphatase-resistant SH2 domain inhibitorsT R Burke, M S Smyth, A Otaka, et al.Journal of Thrombosis and Thrombolysis|December 5, 2019
Reduced dose thrombolysis with ultrasound-facilitated catheter-directed administration for acute pulmonary embolism reduces length of stayNathaniel B Wayne, George A Davis, Tracy E Macaulay, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|January 19, 2008
Individual heterogeneity in platelet response to lysophosphatidic acid: evidence for a novel inhibitory pathwayZehra Pamuklar, Jin Sun Lee, Hsin-Yuan Cheng, et al.Pituitary|April 10, 2012
Bronchial carcinoid tumors metastatic to the sella turcica and review of the literatureOlga Moshkin, Fabio Rotondo, Bernd W Scheithauer, et al.Journal of Thrombosis and Thrombolysis|September 29, 2001
Short-term comparative outcomes associated with the use of GP IIb/IIIa antagonists in patients undergoing coronary interventionC Kimmelstiel, R Phang, A Rehman, et al.Pageof 40